• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖析 PET 示踪剂与皮质基底节变性 tau 纤维的结合特征。

Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.

机构信息

Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20 Uppsala, Sweden.

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 141 84, Stockholm, Sweden.

出版信息

ACS Chem Neurosci. 2021 Sep 15;12(18):3487-3496. doi: 10.1021/acschemneuro.1c00536. Epub 2021 Aug 31.

DOI:10.1021/acschemneuro.1c00536
PMID:34464084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8447187/
Abstract

Alzheimer's disease and primary tauopathies are characterized by the presence of tau pathology in brain. Several tau positron emission tomography (PET) tracers have been developed and studied in Alzheimer's disease (AD), but there is still a lack of 4R-tau specific tracers for non-AD tauopathies. We here present the first computational study on the binding profiles of four tau different PET tracers, PI2620, CBD2115, PM-PBB3, and MK6240, to corticobasal degeneration (CBD) tau. The results showed different preferences for the various binding sites on the 4R fibril, and especially an entry site, a concave site, and a core site showed high binding affinity to these tracers. The core site and entry site both showed higher binding affinity than the surface sites, but the tracers were less likely to enter these sites. PI2620, CBD2115, and PM-PBB3 all showed higher binding affinities to CBD tau than the 3R/4R tracer MK6240. The same strategy has also been applied to AD tau fibrils, and significant differences in selectivity of binding sites were also observed. A higher binding affinity was observed for CBD2115 and PM-PBB3 to AD tau compared to PI2620. None of the studied tracers showed a selectivity for 4R compared to 3R/4R tau. This study clearly shows that identified binding sites from cryo-EM with low resolution can be further refined by metadynamics simulations in order to provide atomic resolution of the binding modes as well as of the thermodynamic properties.

摘要

阿尔茨海默病和原发性 tau 病的特征是脑内存在 tau 病理学。已经开发并研究了几种 tau 正电子发射断层扫描 (PET) 示踪剂用于阿尔茨海默病 (AD),但对于非 AD tau 病仍然缺乏 4R-tau 特异性示踪剂。我们在此首次对四种 tau 不同 PET 示踪剂,即 PI2620、CBD2115、PM-PBB3 和 MK6240,与皮质基底节变性 (CBD) tau 的结合特性进行了计算研究。结果显示,这四种示踪剂对 4R 纤维上的不同结合部位具有不同的偏好性,特别是入口部位、凹面部位和核心部位对这些示踪剂具有高结合亲和力。核心部位和入口部位都比表面部位具有更高的结合亲和力,但示踪剂进入这些部位的可能性较小。PI2620、CBD2115 和 PM-PBB3 对 CBD tau 的结合亲和力均高于 3R/4R 示踪剂 MK6240。同样的策略也应用于 AD tau 纤维,并且观察到结合部位的选择性也有显著差异。与 PI2620 相比,CBD2115 和 PM-PBB3 对 AD tau 的结合亲和力更高。在所研究的示踪剂中,没有一种对 4R 表现出选择性,而对 3R/4R tau 则没有。本研究清楚地表明,通过低温电子显微镜获得的低分辨率结合部位可以通过元动力学模拟进一步细化,以便提供结合模式的原子分辨率以及热力学性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/fa9f7fd3d01b/cn1c00536_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/ffa57159460d/cn1c00536_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/493c507ce716/cn1c00536_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/a7083af662c7/cn1c00536_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/a55faa8cd511/cn1c00536_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/481a60e27cf4/cn1c00536_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/fa9f7fd3d01b/cn1c00536_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/ffa57159460d/cn1c00536_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/493c507ce716/cn1c00536_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/a7083af662c7/cn1c00536_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/a55faa8cd511/cn1c00536_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/481a60e27cf4/cn1c00536_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59cc/8447187/fa9f7fd3d01b/cn1c00536_0006.jpg

相似文献

1
Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.剖析 PET 示踪剂与皮质基底节变性 tau 纤维的结合特征。
ACS Chem Neurosci. 2021 Sep 15;12(18):3487-3496. doi: 10.1021/acschemneuro.1c00536. Epub 2021 Aug 31.
2
Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.tau 纤维中的隐蔽位点解释了 AV-1451 PET 示踪剂对阿尔茨海默病 tau 病的优先结合。
ACS Chem Neurosci. 2021 Jul 7;12(13):2437-2447. doi: 10.1021/acschemneuro.0c00340. Epub 2021 Jun 21.
3
Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.洞察第一代和第二代 PET 示踪剂与 4R 和 3R/4R tau 原纤维的结合。
ACS Chem Neurosci. 2023 Sep 20;14(18):3528-3539. doi: 10.1021/acschemneuro.3c00437. Epub 2023 Aug 28.
4
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.tau PET 示踪剂 PI2620、MK6240 和 RO948 在阿尔茨海默病、皮质基底节变性和进行性核上性麻痹脑中的鉴别结合。
Mol Psychiatry. 2023 Mar;28(3):1272-1283. doi: 10.1038/s41380-022-01875-2. Epub 2022 Nov 29.
5
Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.计算洞察第二代 PET 示踪剂 PI2620 与 Tau 纤维的结合特征。
ACS Chem Neurosci. 2020 Mar 18;11(6):900-908. doi: 10.1021/acschemneuro.9b00578. Epub 2020 Feb 28.
6
Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [F]PI-2620 on Tau Filaments from 3R/4R and 4R Tauopathies.分子模拟揭示了[F]PI-2620对来自3R/4R Tau病和4R Tau病的Tau细丝的不同能量和动力学结合特性。
ACS Chem Neurosci. 2022 Jul 20;13(14):2222-2234. doi: 10.1021/acschemneuro.2c00291. Epub 2022 Jun 28.
7
Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.不同正电子发射断层扫描 Tau 示踪剂与 Tau 纤维上的多个结合位点结合:来自计算建模的见解。
ACS Chem Neurosci. 2018 Jul 18;9(7):1757-1767. doi: 10.1021/acschemneuro.8b00093. Epub 2018 May 2.
8
A Machine Learning-Based Approach to Discrimination of Tauopathies Using [ F]PM-PBB3 PET Images.基于机器学习的 [ F]PM-PBB3 PET 图像对 Tau 病的鉴别方法。
Mov Disord. 2022 Nov;37(11):2236-2246. doi: 10.1002/mds.29173. Epub 2022 Aug 28.
9
In vitro evaluation of [H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies.[H]PI-2620及其结构衍生物在非阿尔茨海默病性tau蛋白病中的体外评估
Nucl Med Biol. 2024 Mar-Apr;130-131:108891. doi: 10.1016/j.nucmedbio.2024.108891. Epub 2024 Feb 19.
10
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.PET配体PBB3和AV-1451与神经退行性tau蛋白病中tau纤维毒株的特异性结合。
Brain. 2017 Mar 1;140(3):764-780. doi: 10.1093/brain/aww339.

引用本文的文献

1
Developing a novel reference region for [F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies.开发用于[F]PI-2620-PET成像的新型参考区域,以促进对4重复tau蛋白病的评估。
Eur J Nucl Med Mol Imaging. 2025 Jun 10. doi: 10.1007/s00259-025-07396-8.
2
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1-indoles as Tauopathy Positron Emission Tomography Radiotracers.2-(杂芳基-环烷基)-1-吲哚作为tau蛋白病正电子发射断层显像剂的构效关系及评价
J Med Chem. 2025 Mar 27;68(6):6462-6492. doi: 10.1021/acs.jmedchem.4c02988. Epub 2025 Mar 11.
3
Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein.

本文引用的文献

1
Binding characteristics of [F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET.[F]PI-2620 的结合特性通过 PET 区分了不同 tau 病中的临床预测 tau 同工型。
J Cereb Blood Flow Metab. 2021 Nov;41(11):2957-2972. doi: 10.1177/0271678X211018904. Epub 2021 May 27.
2
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease.迈向阿尔茨海默病所致痴呆症的 tau PET 示踪剂临床应用。
Alzheimers Dement. 2021 Dec;17(12):1998-2008. doi: 10.1002/alz.12356. Epub 2021 May 13.
3
Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
高效鉴定小分子成像配体在淀粉样蛋白-β、tau 和 α-突触核蛋白上的多个结合位点。
Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):3960-3977. doi: 10.1007/s00259-024-06806-7. Epub 2024 Jul 2.
4
Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research.致病性纤维的冷冻电镜结构及其对神经退行性疾病研究的影响。
Neuron. 2024 Jul 17;112(14):2269-2288. doi: 10.1016/j.neuron.2024.05.012. Epub 2024 Jun 3.
5
Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.用 SV2A PET 示踪剂 UCB-J 追踪阿尔茨海默病大脑中的突触丢失。
Alzheimers Dement. 2024 Apr;20(4):2589-2605. doi: 10.1002/alz.13720. Epub 2024 Feb 16.
6
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids.淀粉样变 cryo-EM 在神经退行性疾病的分子病理学中的应用。
Nature. 2023 Sep;621(7980):701-710. doi: 10.1038/s41586-023-06437-2. Epub 2023 Sep 27.
7
Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.洞察第一代和第二代 PET 示踪剂与 4R 和 3R/4R tau 原纤维的结合。
ACS Chem Neurosci. 2023 Sep 20;14(18):3528-3539. doi: 10.1021/acschemneuro.3c00437. Epub 2023 Aug 28.
8
Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer's disease.tau 正电子发射断层扫描在认知障碍和疑似阿尔茨海默病患者中的应用。
Fukushima J Med Sci. 2023 Aug 10;69(2):85-93. doi: 10.5387/fms.2023-08. Epub 2023 Jun 10.
9
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.tau PET 示踪剂 PI2620、MK6240 和 RO948 在阿尔茨海默病、皮质基底节变性和进行性核上性麻痹脑中的鉴别结合。
Mol Psychiatry. 2023 Mar;28(3):1272-1283. doi: 10.1038/s41380-022-01875-2. Epub 2022 Nov 29.
10
Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain.头对头比较 Tau-PET 放射性配体用于死后 ALS 大脑中 TDP-43 的成像。
Mol Imaging Biol. 2023 Jun;25(3):513-527. doi: 10.1007/s11307-022-01779-1. Epub 2022 Oct 18.
阿尔茨海默病 Tau 丝与 PET 配体 APN-1607 的冷冻电镜结构。
Acta Neuropathol. 2021 May;141(5):697-708. doi: 10.1007/s00401-021-02294-3. Epub 2021 Mar 16.
4
Radiosynthesis, and Evaluation of [F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies.[F]CBD-2115 作为一种用于成像 4R-tau 病的首创类放射性示踪剂的放射性合成及评估。
ACS Chem Neurosci. 2021 Feb 17;12(4):596-602. doi: 10.1021/acschemneuro.0c00801. Epub 2021 Jan 26.
5
Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.伴发痴呆的锥体外系运动障碍的分子影像学:4R tau 病。
Semin Nucl Med. 2021 May;51(3):275-285. doi: 10.1053/j.semnuclmed.2020.12.003. Epub 2021 Jan 8.
6
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update.神经退行性疾病中Tau蛋白病理的影像学:最新进展
Semin Nucl Med. 2021 May;51(3):253-263. doi: 10.1053/j.semnuclmed.2020.12.004. Epub 2020 Dec 20.
7
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.评估 18F-PI-2620 作为进行性核上性麻痹的生物标志物。
JAMA Neurol. 2020 Nov 1;77(11):1408-1419. doi: 10.1001/jamaneurol.2020.2526.
8
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.阿尔茨海默病和非阿尔茨海默病 Tau 病中 Tau 病理学的高对比体内成像。
Neuron. 2021 Jan 6;109(1):42-58.e8. doi: 10.1016/j.neuron.2020.09.042. Epub 2020 Oct 29.
9
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.MK6240 是一种 tau PET 示踪剂,在阿尔茨海默病患者尸检脑组织中的特征分析。
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1093-1102. doi: 10.1007/s00259-020-05035-y. Epub 2020 Sep 24.
10
18F-MK-6240 PET for early and late detection of neurofibrillary tangles.18F-MK-6240 PET 用于早期和晚期检测神经纤维缠结。
Brain. 2020 Sep 1;143(9):2818-2830. doi: 10.1093/brain/awaa180.